https://doi.org/10.1245/s10434-021-11202-8
L
Lauren M. Rosati
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
95
Papers
1.6K
Citations
19
h-index
27
i10-index
Lauren M. Rosati is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Cancer Genomics and Diagnostics & Advanced Radiotherapy Techniques. The author has an h-index of 19, co-authored 81 publications.
ORCID: 0000-0001-6159-9780Papers by this author
worksNeoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity
2022 · Annals of Surgical Oncology · 25 citations
Improving prediction of surgical resectability over current staging guidelines in patients with pancreatic cancer who receive stereotactic body radiation therapy
2018 · Advances in Radiation Oncology · 7 citations
https://doi.org/10.1016/j.adro.2018.07.002
Phase 1 Study of Adjuvant Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Transduced Pancreatic Tumor Cell Vaccine, Low-Dose Cyclophosphamide, and Stereotactic Body Radiation Therapy Followed by FOLFIRINOX in High-Risk Resected Pancreatic Ductal Adenocarcinoma
2024 · International Journal of Radiation Oncology*Biology*Physics · 7 citations
https://doi.org/10.1016/j.ijrobp.2024.10.039
Long-term analysis of 2 prospective studies that incorporate mitomycin C into an adjuvant chemoradiation regimen for pancreatic and periampullary cancers
2017 · Advances in Radiation Oncology · 3 citations
https://doi.org/10.1016/j.adro.2017.07.008
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat